Does TEDIZOLID Cause Hepatic lesion? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hepatic lesion have been filed in association with TEDIZOLID (SIVEXTRO). This represents 1.3% of all adverse event reports for TEDIZOLID.
10
Reports of Hepatic lesion with TEDIZOLID
1.3%
of all TEDIZOLID reports
0
Deaths
3
Hospitalizations
How Dangerous Is Hepatic lesion From TEDIZOLID?
Of the 10 reports, 3 (30.0%) required hospitalization.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEDIZOLID. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does TEDIZOLID Cause?
Off label use (109)
Product use in unapproved indication (93)
Thrombocytopenia (75)
Drug ineffective (73)
Nausea (48)
Pancytopenia (44)
Anaemia (43)
No adverse event (37)
Product availability issue (33)
Neuropathy peripheral (32)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which TEDIZOLID Alternatives Have Lower Hepatic lesion Risk?
TEDIZOLID vs TEDUGLUTIDE
TEDIZOLID vs TEDUGLUTIDE\WATER
TEDIZOLID vs TEGAFUR
TEDIZOLID vs TEGAFUR\URACIL
TEDIZOLID vs TEGASEROD